Sign-up for our newsletter
MAIN
Event Calendar
Awardee Reports
ABOUT DIACOMP
Citing DiaComp
Contact
Committees
Institutions
Awardee Reports
Publications
Bioinformatics
RESOURCES
Protocols & Methods
Reagents & Resources
Mouse Diet
Breeding Schemes
Validation Criteria
IMPC / KOMP Data
Publications
Bioinformatics
CONTACT
PARTICIPANT AREA
Login
▹
Publications
▹
Home
Publication
S6 kinase 1 knockout inhibits uninephrectomy- or diabetes-induced renal
hypertrophy.
Authors
Chen JK, Chen J, Thomas G, Kozma SC, Harris RC
Submitted By
Raymond Harris on 8/11/2010
Status
Published
Journal
American journal of physiology. Renal physiology
Year
2009
Date Published
9/1/2009
Volume : Pages
297 : F585 - F593
PubMed Reference
19474189
Abstract
Removal of one kidney stimulates synthesis of RNA and protein, with minimal DNA
replication, in all nephron segments of the remaining kidney, resulting in cell
growth (increase in cell size) with minimal cell proliferation (increase in cell
number). In addition to the compensatory renal hypertrophy caused by nephron
loss, pathophysiological renal hypertrophy can occur as a consequence of early
uncontrolled diabetes. However, the molecular mechanism underlying renal
hypertrophy in these conditions remains unclear. In the present study, we report
that deletion of S6 kinase 1 (S6K1) inhibited renal hypertrophy seen following
either contralateral nephrectomy or induction of diabetes. In wild-type mice,
hypertrophic stimuli increased phosphorylation of 40S ribosomal protein S6
(rpS6), a known target of S6K1. Immunoblotting analysis revealed that S6K1(-/-)
mice exhibited moderately elevated basal levels of rpS6, which did not increase
further in response to the hypertrophic stimuli. Northern blotting indicated a
moderate upregulation of S6K2 expression in the kidneys of S6K1(-/-) mice.
Phosphorylation of the eukaryotic translation initiation factor 4E-binding
protein 1, another downstream target of the mammalian target of rapamycin
(mTOR), was stimulated to equivalent levels in S6K1(-/-) and S6K1(+/+)
littermates during renal hypertrophy, indicating that mTOR was still activated
in the S6K1(-/-) mice. The highly selective mTOR inhibitor, rapamycin, inhibited
increased phosphorylation of rpS6 and blocked 60-70% of the hypertrophy seen in
wild-type mice but failed to prevent the approximately 10% hypertrophy seen in
S6K1(-/-) mice in response to uninephrectomy (UNX) although it did inhibit the
basal rpS6 phosphorylation. Thus the present study provides the first genetic
evidence that S6K1 plays a major role in the development of compensatory renal
hypertrophy as well as diabetic renal hypertrophy and indicates that UNX- and
diabetes-mediated mTOR activation can selectively activate S6K1 without
activating S6K2.
Investigators with authorship
Name
Institution
Raymond Harris
Vanderbilt University
Complications
All Complications
Bioinformatics
Bone
Cardiomyopathy
Cardiovascular
Gastro-Intestinal (GI)
Nephropathy
Neuropathy & Neurocognition
Pediatric Endocrinology
Retinopathy
Uropathy
Wound Healing
Welcome to the DiaComp Login / Account Request Page.
Email Address:
Password:
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
click here.
ERROR!
There was a problem with the page:
User Info
User Confirm
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!